Scientists Develop Drug that Slows Alzheimer’s in Mice
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer’s disease in aged mice following short-term treatment.
Sensational Success in Patients with Major Depression Using Deep Brain Stimulation
Researchers implanted pacemaker electrodes into the medial forebrain bundle of patients suffering from major depression and performed deep brain stimulation. In a matter of days, in six out of seven patients, symptoms such as anxiety, despondence, listlessness and joylessness had improved considerably.
Atypical Brain Circuits May Cause Slower Gaze Shifting in Infants Who Later Develop Autism
Infants at 7 months of age who go on to develop autism are slower to reorient their gaze and attention from one object to another when compared to 7-month-olds who do not develop autism, and this behavioral pattern is in part explained by atypical brain circuits.
Buphenyl Identified as a Possible Drug for Alzheimer’s Disease
Buphenyl (sodium phenylbutyrate), a medication approved for the treatment of hyperammonemia, could help prevent the progression of Alzheimer’s disease, a new study finds.
Researchers Identify Possible Treatment Window for Memory Problems
A new study identifies a potential treatment window of several years for plaques in the brain considered to cause memory loss in diseases such as Alzheimer’s.
Network Analysis of the Brain may Explain Features of Autism
Researchers find that, compared with neurotypical children, those with autism have multiple redundant connections between neighboring brain areas at the expense of long-distance links.
Researchers Find Controlling Element of Huntington’s Disease
Researchers discover a three molecule complex could be a target for treating Huntington’s Disease, a genetic and currently incurable brain disease which causes movement disorders and dementia.
Sweet News for Stem Cell’s ‘Holy Grail’
Using a sugar-coated scaffold, researchers move closer to unlocking the therapeutic use of stem cells to treat a wide range of diseases from Alzheimer’s to diabetes.
Novel Combination Therapy Shuts Down Escape Route, Killing Glioblastoma Tumor Cells
A new study discovers molecular pathways that could lead to new targeted therapies which may potentially treat Glioblastoma, the most common and lethal form of brain cancer in adults.
Scientists Find Genes Linked to Human Neurological Disorders in Sea Lamprey Genome
Scientists have identified several genes linked to human neurological disorders, such as Alzheimer’s disease, Parkinson’s disease and spinal cord injury, in the sea lamprey. The lamprey has large, identified neurons in its brain and spinal cord, making it an excellent model to study regeneration at the single cell-level.
